Determinants of healthy diet choices during austerity in GreeceBRITISH FOOD JOURNALIF4.22021-11-095PRE
Two Sides of the Same Coin? A Dual Multiple Criteria Decision Analysis of Novel Treatments Against Rheumatoid Arthritis in Physicians and PatientsCLINICAL THERAPEUTICSIF3.62021-09-014PREAI
PERCEPTIONS OF THE GREEK POPULATION CONCERNING MEDICINES - A DESCRIPTIVE ANALYSISVALUE IN HEALTHIF62018-10-010OAAI
WHAT ARE THE VIEWS AND PERCEPTIONS OF THE GREEK POPULATION TOWARDS THE PHARMACEUTICAL INDUSTRY?VALUE IN HEALTHIF62018-10-010OAAI
SOCIOECONOMIC AND HEALTH-RELATED FACTORS ASSOCIATED WITH ADHERENCE TO CHRONIC MEDICATION IN GREECEVALUE IN HEALTHIF62018-10-010OAAI
THE DEVELOPMENT AND EMPIRICAL APPLICATION OF A MULTIPLE SOCIETAL VALUE CRITERIA APPROACH TO RESOURCE ALLOCATION AMONG DISEASE CATEGORIESVALUE IN HEALTHIF62018-10-010OAAI
COST EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH MULTIPLE SCLEROSIS IN GREECEVALUE IN HEALTHIF62018-10-011OAAI
OUT-OF-POCKET EXPENDITURE FOR PRESCRIBED AND OVER-THE-COUNTER MEDICATIONS IN GREECEVALUE IN HEALTHIF62018-10-010OAAI
COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTSVALUE IN HEALTHIF62018-10-010OAAI
COST-EFFECTIVENESS ANALYSIS OF TOFACITINIB IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS IN GREECEVALUE IN HEALTHIF62018-10-012OAAI
Are happy people healthier? An instrumental variable approach using data from GreeceJOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTHIF3.72018-07-206OAAI
UNMET HEALTHCARE NEEDS DUE TO FINANCIAL REASONS IN TIMES OF AUSTERITYVALUE IN HEALTHIF62017-10-011OAAI
POSITIVE EXTERNALITIES OF AUSTERITY? THE CASE OF SMOKING CESSATION DURING THE FINANCIAL CRISIS IN GREECEVALUE IN HEALTHIF62017-10-010OAAI
A COST-OF-ILLNESS ANALYSIS FOR COMMUNITY ACQUIRED PNEUMONIA IN GREECEVALUE IN HEALTHIF62017-10-010OAAI
BARRIERS TO ACCESS AND PRICING NEGOTIATIONS CRITERIAL SELECTION FOR NOVEL TREATMENTS FOR HEPATITIS C IN THE GREEK HEALTHCARE CONTEXTVALUE IN HEALTHIF62017-10-010OAAI
COST-MINIMIZATION ANALYSIS OF HPV 16/18 GENOTYPING TEST VERSUS HPV REFLEX GENOTYPING FOR CERVICAL CANCER SCREENINGVALUE IN HEALTHIF62017-10-010OAAI
BUDGET IMPACT MODEL OF COBIMETINIB IN COMBINATION WITH VEMURAFENIB FOR PREVIOUSLY UNTREATED BRAF V600-MUTATION POSITIVE PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC MELANOMAVALUE IN HEALTHIF62017-10-010OAAI